Search results for “site:ncbi.nlm.nih.gov”

Page 35 of about 437 results

ncbi.nlm.nih.gov pubmed › 33320880

Human agency and infection rates: Implications for social distancing during epidemics

Social distancing is an important measure in controlling epidemics. This paper presents a simple theoretical model focussed on the implications of the wide range in interaction rates between individuals, both within the workplace and in...

ncbi.nlm.nih.gov pubmed › 33322035

Comparison of Rapid Antigen Tests for COVID-19

Reverse transcription-quantitative PCR (RT-qPCR)-based tests are widely used to diagnose coronavirus disease 2019 (COVID-19). As a result that these tests cannot be done in local clinics where RT-qPCR testing capability is lacking, rapid...

ncbi.nlm.nih.gov pubmed › 33338197

Reinfection With SARS-CoV-2: Implications for Vaccines

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become pandemic and the duration of protective immunity to the virus is unknown. Cases of persons reinfected with the virus are being reported with increasing...

ncbi.nlm.nih.gov pubmed › 33342556

Mortality of covid-19 patients with vascular thrombotic complications

The venous thromboembolic risk in these patients is greater than the arterial, but arterial thrombosis when it occurs was associated with high mortality rates. Survival was better in patients with DVT and PE than in patients with ischemic stroke or PAT.

ncbi.nlm.nih.gov pubmed › 33355522

Healing after COVID-19: are survivors at risk for pulmonary fibrosis?

The novel SARS-CoV-2 coronavirus, which is responsible for COVID-19 disease, was first reported in Wuhan, China, in December of 2019. The virus rapidly spread, and the World Health Organization declared a pandemic by March 2020. With...

ncbi.nlm.nih.gov pubmed › 33364262

Ventilator associated lung injury in severe COVID-19 pneumonia patients - Case Reports: Ventilator associated lung injury in COVID-19

Management of severe coronavirus disease 2019 requires advanced respiratory support modalities including invasive mechanical ventilation (IMV), continuous positive airway pressure (C-PAP), and non-invasive ventilation ((NIV). IMV leads to...

ncbi.nlm.nih.gov pubmed › 33394351

Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19

Coronavirus disease 2019 (COVID-19), reminiscent of the severe acute respiratory syndrome (SARS) outbreak in 2003, has been a tragic disaster to people all over the world. As there is no specific drug for COVID-19, neutralizing antibodies...

Try “site:ncbi.nlm.nih.gov” on: Marginalia · Mojeek · Wiby · DuckDuckGo · Bing · Google · Wikipedia · Internet Archive